Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Colloids Surf B Biointerfaces. 2011 Oct 20;99:82–94. doi: 10.1016/j.colsurfb.2011.10.029

Table 1. Amphiphilic HA derivatives for imaging or drug delivery.

Carrier Additional hydrophilic substituent Hydrophobic moiety Structure of hydrophobic moiety Drug Ref.
HA-g-TDA - TDA graphic file with name nihms338327t1.jpg - [142]
HA-g-CA -/PEG CA graphic file with name nihms338327t2.jpg - [143-144, 148]
HA-g-PEG-PCL PEG PCL graphic file with name nihms338327t3.jpg DOX [145]
HA-g-PEG-PLGA PEG PLGA graphic file with name nihms338327t4.jpg DOX [141]
HA-g-PLGA - PLGA graphic file with name nihms338327t5.jpg DOX [146]
HA-g-Oligo(VBODENA) - Oligo(VBODENA) graphic file with name nihms338327t6.jpg PTX [147]
HA-b-PBLG - PBLG graphic file with name nihms338327t7.jpg DOX, DTX [150-151]

Abbreviations: TDA = tertradecylamine; CA = 5b-cholanic acid; PCL = poly(caprolactone); PLGA = poly(lactic-co-glycolic acid); PEG = polyethylene glycol); oligo(VBODENA) = oligo(2-(4-(vinylbenzyloxy)-N, N-diethylnicotinamide)); and PBLG = poly(γ-benzyl-glutamate).